Post-approval studies (Phase 4)Looking for participantsNCT06964269
What this trial is testing
Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Who this might be right for
Autoimmune DiseasesDry EyeNeurotrophic Keratitis
Toyos Clinic 20